ISIN Update: Nanobiotix Announces Results
ISIN.net news update announces 6 month results: NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces its half year results for the six months ended 30 June 2015. Financial highlights: Total revenue of circa €1.7m (H1 2014: €1m) includes the pro-rata share…